Caplin Point Laboratories informs about press release

12 Jun 2023 Evaluate
Caplin Point Laboratories has informed that it has enclosed a Press Release regarding grant of United States Food and Drug Administration (USFDA) approval for the Abbreviated New Drug Application (ANDA) Cisatracurium Besylate Injection USP to its Subsidiary Caplin Steriles.

The above information is a part of company’s filings submitted to BSE.

Caplin Point Lab Share Price

1917.10 -1.05 (-0.05%)
29-Dec-2025 10:06 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.10
Dr. Reddys Lab 1267.00
Cipla 1504.80
Zydus Lifesciences 907.90
Lupin 2101.10
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×